Here's what patients can expect from our program: 15%+ body weight loss : In the STEP 1 trial published in the New England Journal of Medicine , patients using semaglutide lost an average of roughly 15% of their body weight
Besides, semaglutide GLP-1 increases the bodys metabolic rate and promotes fat oxidation, contributing to weight loss
During short, strenuous exercise sessions, like lifting heavy weights and sprinting, the body utilises ATP (adenosine triphosphate) for quick energy
Comprehensive literature searches were performed in PubMed, Web of Science, and Google Scholar (title search only) up to January 31, 2025
Today, theyre a fully loaded magazine of silver bullets aimed at obesity, addiction, cancer, sleep apnea, and a growing list of other diseases and chronic conditions